Athersys (ATHX) Reports Q3 Loss of $0.07/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. SPY
2. NVDA
3. PTC
4. META
5. PCVX
6. USO
7. MSFT
8. AMD
9. ATH
10. KLC

Go back to Athersys (ATHX) Reports Q3 Loss of $0.07/sh

Athersys Reports Third Quarter 2021 Results and Provides Corporate Update

November 15, 2021 4:05 PM EST

Positive topline data for ARDS study and completion of enrollment in Japan ischemic stroke study are important milestones for development and potential commercialization of MultiStem® cell therapy

Management to host conference call at 4:30 pm EST today

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended September 30, 2021 and provided a corporate update.

The third quarter brought several important milestones in the development and potential commercialization of MultiStem® cell therapy, stated Mr. William (B.J.)... More